Back
ESC Premium Access

Comparative effectiveness and safety between non-VKA oral anticoagulants in non-valvular atrial fibrillation patients with differential duration of treatment: an analysis of the ARISTOPHANES study

Session: Poster Session 5 - Atrial fibrillation and oral anticoagulation 3
Topic: Oral Anticoagulation
Speaker: Doctor X. Li (Princeton, US)
Event: ESC Congress 2019

Congress Presentation

Add to my library

Like

About the speaker

Doctor Xiaoyan Li

Princeton (United States of America)
0 follower

7 more presentations in this session

Men who live alone have poor anticoagulation control: results from Danish registries.

Speaker: Doctor A. Nissen Bonde (Gentofte, DK)

Access
Abstract
Slides
Like
Thumbnail

Edoxaban Treatment in routiNe clinical prActice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe): 1-year follow-up according to body mass index

Speaker: Professor T. Weiss (St. Polten, AT)

Access
Abstract
Like
Thumbnail

VTE-BLEED score predicts major bleeding in patients with atrial fibrillation

Speaker: Professor E. Klok (Leiden, NL)

Access
Abstract
Like
Thumbnail

Optimal rivaroxaban dose in asian patients with atrial fibrillation and normal or mildly impaired renal function

Speaker: Doctor E. Choi (Seoul, KR)

Access
Abstract
Like
Thumbnail

Antithrombotic challenge in the clinical dilemma of high-risk patients with atrial fibrillation: one-year result from ChiOTEAF Registry

Speaker: Professor Y. Guo (Beijing, CN)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster Session 5 - Atrial fibrillation and oral anticoagulation 3

Speakers: Doctor X. Li, Doctor A. Nissen Bonde, Professor T. Weiss, Professor E. Klok, Doctor E. Choi...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources